FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:TOP1-CDH4

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: TOP1-CDH4
FusionPDB ID: 93066
FusionGDB2.0 ID: 93066
HgeneTgene
Gene symbol

TOP1

CDH4

Gene ID

7150

1002

Gene nameDNA topoisomerase Icadherin 4
SynonymsTOPICAD4|R-CAD|RCAD
Cytomap

20q12

20q13.33

Type of geneprotein-codingprotein-coding
DescriptionDNA topoisomerase 1Scl-70 antigentopoisomerase (DNA) Itype I DNA topoisomerasecadherin-4R-cadherincadherin 4, type 1, R-cadherin (retinal)cadherin 4, type 1, preproproteinretinal cadherin
Modification date2020031320200313
UniProtAcc.

P55283

Main function of 5'-partner protein: FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. May play an important role in retinal development.
Ensembl transtripts involved in fusion geneENST idsENST00000361337, ENST00000543233, 
ENST00000360469, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score15 X 6 X 10=90016 X 14 X 7=1568
# samples 2021
** MAII scorelog2(20/900*10)=-2.16992500144231
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(21/1568*10)=-2.90046432644909
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: TOP1 [Title/Abstract] AND CDH4 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: TOP1 [Title/Abstract] AND CDH4 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)TOP1(39658095)-CDH4(60318619), # samples:3
Anticipated loss of major functional domain due to fusion event.TOP1-CDH4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
TOP1-CDH4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
TOP1-CDH4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
TOP1-CDH4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneTOP1

GO:0006265

DNA topological change

14594810



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr20:39658095/chr20:60318619)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across TOP1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across CDH4 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000361337TOP1chr2039658095+ENST00000360469CDH4chr2060318619+6562308312889952
ENST00000361337TOP1chr2039658095+ENST00000360469CDH4chr2060318618+6562308312889952

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000361337ENST00000360469TOP1chr2039658095+CDH4chr2060318619+0.0032800950.9967199
ENST00000361337ENST00000360469TOP1chr2039658095+CDH4chr2060318618+0.0032800950.9967199

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for TOP1-CDH4

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
TOP1chr2039658095CDH4chr206031861830890HLHNDSQIEADFRLNVKFSSCVGTKG
TOP1chr2039658095CDH4chr206031861930890HLHNDSQIEADFRLNVKFSSCVGTKG

Top

Potential FusionNeoAntigen Information of TOP1-CDH4 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
TOP1-CDH4_39658095_60318618.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
TOP1-CDH4chr2039658095chr2060318618308HLA-B45:01IEADFRLNV0.99730.7944716
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:21SQIEADFRL0.98080.6856514
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:24SQIEADFRL0.97570.5472514
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:30SQIEADFRL0.97570.5472514
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:67SQIEADFRL0.97570.5472514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:24SQIEADFRL0.94580.6785514
TOP1-CDH4chr2039658095chr2060318618308HLA-B13:02SQIEADFRL0.940.5516514
TOP1-CDH4chr2039658095chr2060318618308HLA-B13:01SQIEADFRL0.89110.9461514
TOP1-CDH4chr2039658095chr2060318618308HLA-B44:03ADFRLNVKF0.88730.8717918
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:29SQIEADFRL0.85910.5435514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:01SQIEADFRL0.85050.9508514
TOP1-CDH4chr2039658095chr2060318618308HLA-B08:09RLNVKFSSC0.8490.51561221
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:20SQIEADFRL0.84580.5536514
TOP1-CDH4chr2039658095chr2060318618308HLA-B13:01ADFRLNVKF0.78560.8799918
TOP1-CDH4chr2039658095chr2060318618308HLA-B47:01SQIEADFRL0.78320.5277514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:13SQIEADFRL0.76420.951514
TOP1-CDH4chr2039658095chr2060318618308HLA-B38:01SQIEADFRL0.76340.9767514
TOP1-CDH4chr2039658095chr2060318618308HLA-B38:02SQIEADFRL0.74140.9754514
TOP1-CDH4chr2039658095chr2060318618308HLA-B41:01IEADFRLNV0.70180.89716
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:10SQIEADFRL0.66740.7265514
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:03SQIEADFRL0.66260.9136514
TOP1-CDH4chr2039658095chr2060318618308HLA-B50:01IEADFRLNV0.60180.6194716
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:37SQIEADFRL0.44920.705514
TOP1-CDH4chr2039658095chr2060318618308HLA-B52:01IEADFRLNV0.28580.8895716
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:13IEADFRLNV0.12670.909716
TOP1-CDH4chr2039658095chr2060318618308HLA-B52:01SQIEADFRL0.07020.9734514
TOP1-CDH4chr2039658095chr2060318618308HLA-B44:03IEADFRLNVKF0.99980.8472718
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:21SQIEADFRLNV0.98560.6817516
TOP1-CDH4chr2039658095chr2060318618308HLA-B13:02SQIEADFRLNV0.96430.7374516
TOP1-CDH4chr2039658095chr2060318618308HLA-B40:06IEADFRLNV0.99970.5355716
TOP1-CDH4chr2039658095chr2060318618308HLA-B27:14FRLNVKFSS0.9980.75291120
TOP1-CDH4chr2039658095chr2060318618308HLA-B73:01FRLNVKFSS0.99060.54051120
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:01SQIEADFRL0.97570.5472514
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:04SQIEADFRL0.88930.9693514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:09SQIEADFRL0.88040.7042514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:08SQIEADFRL0.7710.9205514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:05SQIEADFRL0.75030.9413514
TOP1-CDH4chr2039658095chr2060318618308HLA-C02:06SQIEADFRL0.74090.9636514
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:05SQIEADFRL0.65550.9367514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:08IEADFRLNV0.56080.8118716
TOP1-CDH4chr2039658095chr2060318618308HLA-B51:07IEADFRLNV0.2390.7878716
TOP1-CDH4chr2039658095chr2060318618308HLA-B40:04IEADFRLNV0.99620.6992716
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:14SQIEADFRL0.98160.5287514
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:06SQIEADFRL0.98080.6856514
TOP1-CDH4chr2039658095chr2060318618308HLA-B27:09SQIEADFRL0.95740.8478514
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:73SQIEADFRL0.89320.9598514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:02SQIEADFRL0.8910.9536514
TOP1-CDH4chr2039658095chr2060318618308HLA-B44:26ADFRLNVKF0.88730.8717918
TOP1-CDH4chr2039658095chr2060318618308HLA-B44:07ADFRLNVKF0.88730.8717918
TOP1-CDH4chr2039658095chr2060318618308HLA-B44:13ADFRLNVKF0.88730.8717918
TOP1-CDH4chr2039658095chr2060318618308HLA-B18:03IEADFRLNV0.8750.9248716
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:53SQIEADFRL0.85580.9324514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:31SQIEADFRL0.85350.9511514
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:30SQIEADFRL0.83920.834514
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:54SQIEADFRL0.77370.9302514
TOP1-CDH4chr2039658095chr2060318618308HLA-B38:05SQIEADFRL0.76340.9767514
TOP1-CDH4chr2039658095chr2060318618308HLA-B48:02SQIEADFRL0.74960.9515514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:11SQIEADFRL0.74620.8927514
TOP1-CDH4chr2039658095chr2060318618308HLA-B35:13SQIEADFRL0.71130.9366514
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:20SQIEADFRL0.65070.9558514
TOP1-CDH4chr2039658095chr2060318618308HLA-B35:28SQIEADFRL0.64770.959514
TOP1-CDH4chr2039658095chr2060318618308HLA-B50:05IEADFRLNV0.60180.6194716
TOP1-CDH4chr2039658095chr2060318618308HLA-B50:04IEADFRLNV0.60180.6194716
TOP1-CDH4chr2039658095chr2060318618308HLA-B15:09SQIEADFRL0.43690.868514
TOP1-CDH4chr2039658095chr2060318618308HLA-B39:02IEADFRLNV0.14950.913716
TOP1-CDH4chr2039658095chr2060318618308HLA-B44:13IEADFRLNVKF0.99980.8472718
TOP1-CDH4chr2039658095chr2060318618308HLA-B44:07IEADFRLNVKF0.99980.8472718
TOP1-CDH4chr2039658095chr2060318618308HLA-B44:26IEADFRLNVKF0.99980.8472718
TOP1-CDH4chr2039658095chr2060318618308HLA-B18:11IEADFRLNVKF0.99950.7116718
TOP1-CDH4chr2039658095chr2060318618308HLA-A02:06SQIEADFRLNV0.98560.6817516

Top

Potential FusionNeoAntigen Information of TOP1-CDH4 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
TOP1-CDH4_39658095_60318618.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
TOP1-CDH4chr2039658095chr2060318618308DRB1-0301DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0301NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0301HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0301SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0303DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0303NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0303HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0303SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0305DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0305NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0305HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0307DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0307NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0307HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0307SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0310DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0310NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0310HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0310SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0313DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0313NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0313HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0313SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0315DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0315NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0315HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0315SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0318DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0318NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0318HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0318SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0320DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0320NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0320HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0320SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0322DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0322NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0322HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0322SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0324DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0324NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0324HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0324SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0326DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0326NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0326HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0326SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0328DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0328NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0328HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0328SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0330DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0330NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0330HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0330SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0332DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0332NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0332HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0332SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0334DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0334NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0334HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0334SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0336DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0336NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0336HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0336SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0338DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0338NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0340DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0340NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0340HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0342DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0342NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0342HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0344DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0344NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0344HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0344SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0346DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0346NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0346HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0346SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0348DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0348NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0348HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0348SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0350DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0350NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0350HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0350SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0352DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0352NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0352HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0352SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-0354DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-0354NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-0354HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-0354SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-1107DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1107NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1107HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1107SQIEADFRLNVKFSS520
TOP1-CDH4chr2039658095chr2060318618308DRB1-1117DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1127EADFRLNVKFSSCVG823
TOP1-CDH4chr2039658095chr2060318618308DRB1-1152DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1153EADFRLNVKFSSCVG823
TOP1-CDH4chr2039658095chr2060318618308DRB1-1179DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1179NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1333DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1385EADFRLNVKFSSCVG823
TOP1-CDH4chr2039658095chr2060318618308DRB1-1394DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1394NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1394HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1396EADFRLNVKFSSCVG823
TOP1-CDH4chr2039658095chr2060318618308DRB1-1401DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1405DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1408DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1419DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1421DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1421NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1421HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1423DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1424EADFRLNVKFSSCVG823
TOP1-CDH4chr2039658095chr2060318618308DRB1-1426DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1432DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1432NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1434DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1434NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1438DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1438NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1438HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1443DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1443NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1445DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1450DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1450NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1450HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1454DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1456DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1458DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1459DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1460DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1462DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1470DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1475DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1475NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1476DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1476NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1476HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1479DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1479NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1479HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1480DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1482DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1482NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1482HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1486DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1487DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1488DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1490DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1491DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1493DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1493NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1495DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1495NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB1-1495HNDSQIEADFRLNVK217
TOP1-CDH4chr2039658095chr2060318618308DRB1-1496DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1497DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1498EADFRLNVKFSSCVG823
TOP1-CDH4chr2039658095chr2060318618308DRB1-1499DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB1-1499NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB3-0114DSQIEADFRLNVKFS419
TOP1-CDH4chr2039658095chr2060318618308DRB3-0114NDSQIEADFRLNVKF318
TOP1-CDH4chr2039658095chr2060318618308DRB3-0114HNDSQIEADFRLNVK217

Top

Fusion breakpoint peptide structures of TOP1-CDH4

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
7316QIEADFRLNVKFSSTOP1CDH4chr2039658095chr2060318618308

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of TOP1-CDH4

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN7316QIEADFRLNVKFSS-5.47913-5.67113
HLA-B14:023BVN7316QIEADFRLNVKFSS-3.84443-4.60543
HLA-B52:013W397316QIEADFRLNVKFSS-6.76995-6.96195
HLA-B52:013W397316QIEADFRLNVKFSS-5.58751-6.34851
HLA-A11:014UQ27316QIEADFRLNVKFSS-5.74663-6.50763
HLA-A11:014UQ27316QIEADFRLNVKFSS-5.69582-5.88782
HLA-A24:025HGA7316QIEADFRLNVKFSS-8.42283-9.18383
HLA-A24:025HGA7316QIEADFRLNVKFSS-7.2103-7.4023
HLA-B27:056PYJ7316QIEADFRLNVKFSS-7.69112-7.88312
HLA-B44:053DX87316QIEADFRLNVKFSS-5.89348-6.08548
HLA-B44:053DX87316QIEADFRLNVKFSS-3.81554-4.57654
HLA-A02:016TDR7316QIEADFRLNVKFSS-3.68024-4.44124

Top

Vaccine Design for the FusionNeoAntigens of TOP1-CDH4

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
TOP1-CDH4chr2039658095chr20603186181120FRLNVKFSSTGAATGTCAAGTTCAGCAGCTGTGTGG
TOP1-CDH4chr2039658095chr20603186181221RLNVKFSSCATGTCAAGTTCAGCAGCTGTGTGGGGA
TOP1-CDH4chr2039658095chr2060318618514SQIEADFRLTCGAAGCGGATTTCCGATTGAATGTCA
TOP1-CDH4chr2039658095chr2060318618516SQIEADFRLNVTCGAAGCGGATTTCCGATTGAATGTCAAGTTCA
TOP1-CDH4chr2039658095chr2060318618716IEADFRLNVCGGATTTCCGATTGAATGTCAAGTTCA
TOP1-CDH4chr2039658095chr2060318618718IEADFRLNVKFCGGATTTCCGATTGAATGTCAAGTTCAGCAGCT
TOP1-CDH4chr2039658095chr2060318618918ADFRLNVKFTCCGATTGAATGTCAAGTTCAGCAGCT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
TOP1-CDH4chr2039658095chr2060318618217HNDSQIEADFRLNVKATTCCCAGATCGAAGCGGATTTCCGATTGAATGTCAAGTTCAGCA
TOP1-CDH4chr2039658095chr2060318618318NDSQIEADFRLNVKFCCCAGATCGAAGCGGATTTCCGATTGAATGTCAAGTTCAGCAGCT
TOP1-CDH4chr2039658095chr2060318618419DSQIEADFRLNVKFSAGATCGAAGCGGATTTCCGATTGAATGTCAAGTTCAGCAGCTGTG
TOP1-CDH4chr2039658095chr2060318618520SQIEADFRLNVKFSSTCGAAGCGGATTTCCGATTGAATGTCAAGTTCAGCAGCTGTGTGG
TOP1-CDH4chr2039658095chr2060318618823EADFRLNVKFSSCVGATTTCCGATTGAATGTCAAGTTCAGCAGCTGTGTGGGGACCAAGG

Top

Information of the samples that have these potential fusion neoantigens of TOP1-CDH4

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LUADTOP1-CDH4chr2039658095ENST00000361337chr2060318618ENST00000360469TCGA-05-4244

Top

Potential target of CAR-T therapy development for TOP1-CDH4

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneCDH4chr20:39658095chr20:60318618ENST00000360469116735_7560917.0TransmembraneHelical
TgeneCDH4chr20:39658095chr20:60318618ENST00000543233015735_7560843.0TransmembraneHelical
TgeneCDH4chr20:39658095chr20:60318619ENST00000360469116735_7560917.0TransmembraneHelical
TgeneCDH4chr20:39658095chr20:60318619ENST00000543233015735_7560843.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to TOP1-CDH4

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to TOP1-CDH4

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource